Guanhao BiotechLtd Balance Sheet Health
Financial Health criteria checks 6/6
Guanhao BiotechLtd has a total shareholder equity of CN¥471.1M and total debt of CN¥84.1M, which brings its debt-to-equity ratio to 17.8%. Its total assets and total liabilities are CN¥730.3M and CN¥259.2M respectively. Guanhao BiotechLtd's EBIT is CN¥9.4M making its interest coverage ratio -12.1. It has cash and short-term investments of CN¥106.6M.
Key information
17.8%
Debt to equity ratio
CN¥84.08m
Debt
| Interest coverage ratio | -12.1x |
| Cash | CN¥106.65m |
| Equity | CN¥471.07m |
| Total liabilities | CN¥259.25m |
| Total assets | CN¥730.32m |
Recent financial health updates
No updates
Recent updates
Solid Earnings May Not Tell The Whole Story For Guanhao BiotechLtd (SZSE:300238)
Nov 04
Subdued Growth No Barrier To Guanhao Biotech Co.,Ltd. (SZSE:300238) With Shares Advancing 38%
Oct 24Optimistic Investors Push Guanhao Biotech Co.,Ltd. (SZSE:300238) Shares Up 28% But Growth Is Lacking
Sep 02Guanhao Biotech Co.,Ltd. (SZSE:300238) May Have Run Too Fast Too Soon With Recent 28% Price Plummet
Jun 07Guanhao Biotech Co.,Ltd.'s (SZSE:300238) 26% Share Price Plunge Could Signal Some Risk
Apr 23Guanhao Biotech Co.,Ltd.'s (SZSE:300238) 32% Share Price Surge Not Quite Adding Up
Mar 09Financial Position Analysis
Short Term Liabilities: 300238's short term assets (CN¥273.6M) exceed its short term liabilities (CN¥164.3M).
Long Term Liabilities: 300238's short term assets (CN¥273.6M) exceed its long term liabilities (CN¥95.0M).
Debt to Equity History and Analysis
Debt Level: 300238 has more cash than its total debt.
Reducing Debt: 300238's debt to equity ratio has reduced from 25.2% to 17.8% over the past 5 years.
Debt Coverage: 300238's debt is well covered by operating cash flow (31.6%).
Interest Coverage: 300238 earns more interest than it pays, so coverage of interest payments is not a concern.